임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
21건 표시
- 3상모집 중· Menorrhagiato Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
리드: JW중외제약
- 3상완료· Type 2 Diabetes MellitusTo Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM
리드: JW중외제약
- 3상완료· Type 2 Diabetes MellitusTo Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus
리드: JW중외제약
- 3상완료· DyslipidemiaTo Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
리드: JW중외제약
- 3상완료· Primary HypercholesterolemiaTo Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia
리드: JW중외제약
- 3상완료· Anemia of Chronic Kidney DiseaseA Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
리드: JW중외제약
- 3상모집 중단 (진행 중)· Rectal CancerConsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy
협력: JW중외제약
- 3상상태 미확인· Myocardial InfarctionEffects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction
협력: JW중외제약
- 3상완료· Erectile DysfunctionThis Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.
리드: JW중외제약
- 3상완료· Type 2 Diabetes MellitusEfficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone
리드: JW중외제약
- 3상완료· Type 2 Diabetes MellitusA Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients
리드: JW중외제약
- 3상완료· Rheumatoid ArthritisEfficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
리드: JW중외제약
- 3상완료· Erectile DysfunctionTherapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil
리드: JW중외제약
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.